In a letter dated December 18, the drug regulator said that FDC (fixed-dose combination) chlorpheniramine maleate and phenylephrine should not be given to children aged under four. It also said that the firms manufacturing it should carry a warning in this regard on the medicine label and package insert. The decision was taken after a review by a sub-committee of experts.